Advertisement

General Thoracic and Cardiovascular Surgery

, Volume 60, Issue 6, pp 386–390 | Cite as

Very-low-dose continuous drip infusion of landiolol hydrochloride for postoperative atrial tachyarrhythmia in patients with poor left ventricular function

  • Akimasa MorisakiEmail author
  • Mitsuharu Hosono
  • Yasuyuki Sasaki
  • Hidekazu Hirai
  • Masanori Sakaguchi
  • Atsushi Nakahira
  • Hiroyuki Seo
  • Shigefumi Suehiro
Case Report

Abstract

Three patients with poor left ventricular function (left ventricular ejection fraction <30 %) developed postoperative atrial tachyarrhythmia in intensive care. Case 1 was a 64-year-old man who underwent a modified Bentall procedure and mitral valve annuloplasty. Case 2 was a 63-year-old woman who underwent quintuple coronary artery bypass grafting. Case 3 was a 65-year-old man who underwent mitral valve replacement. Preoperative intra-aortic balloon pumping was required in Cases 2 and 3. Excellent heart rate control with no hemodynamic deterioration was achieved in all three cases by very-low-dose continuous drip infusion of landiolol hydrochloride (2–5 μg/kg/min). Very-low-dose continuous drip infusion of landiolol hydrochloride is a safe and useful alternative for the control of perioperative atrial tachyarrhythmias in patients with poor left ventricular function.

Keywords

Landiolol Left ventricular dysfunction Atrial arrhythmia Postoperative complications 

References

  1. 1.
    Echahidi N, Pibarot P, O’Hara G, Mathieu P. Mechanisms, prevention, and treatment of atrial fibrillation after cardiac surgery. J Am Coll Cardiol. 2008;51:793–801.PubMedCrossRefGoogle Scholar
  2. 2.
    Iguchi S, Iwamura H, Nishizaki M, Hayashi A, Senokuchi K, Kobayashi K, et al. Development of a highly cardioselective ultra short-acting beta-blocker, ONO-1101. Chem Pharm Bull (Tokyo). 1992;40:1462–9.CrossRefGoogle Scholar
  3. 3.
    Yoshida Y, Terajima K, Sato C, Akada S, Miyagi Y, Hongo T, et al. Clinical role and efficacy of landiolol in the intensive care unit. J Anesth. 2008;22:64–9.PubMedCrossRefGoogle Scholar
  4. 4.
    Atarashi H, Kuruma A, Yashima M, Saitoh H, Ino T, Endoh Y, et al. Pharmacokinetics of landiolol hydrochloride, a new ultra-short-acting beta-blocker, in patients with cardiac arrhythmias. Clin Pharmacol Ther. 2000;68:143–50.PubMedCrossRefGoogle Scholar
  5. 5.
    Wariishi S, Yamashita K, Nishimori H, Fukutomi T, Yamamoto M, Radhakrishnan G, et al. Postoperative administration of landiolol hydrochloride for patients with supraventricular arrhythmia: the efficacy of sustained intravenous infusion at a low dose. Interact Cardiovasc Thorac Surg. 2009;9:811–3.PubMedCrossRefGoogle Scholar
  6. 6.
    Yamamoto S, Goto K, Ohchi Y, Yasuda N, Shingu C, Noguchi T. Conversion of atrial flutter to sinus rhythm during landiolol infusion. J Anesth. 2010;24:107–9.PubMedCrossRefGoogle Scholar
  7. 7.
    Goto K, Shingu C, Miyamoto S, Miyakawa H, Noguchi T. The effect of landiolol on hemodynamics and left ventricular function in patients with coronary artery disease. J Clin Anesth. 2007;19:523–9.PubMedCrossRefGoogle Scholar
  8. 8.
    Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation—executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). J Am Coll Cardiol. 2006;48:854–906.PubMedCrossRefGoogle Scholar
  9. 9.
    Gorczynski RJ. Basic pharmacology of esmolol. Am J Cardiol. 1985;56:3F–13F.PubMedCrossRefGoogle Scholar
  10. 10.
    Ikeshita K, Nishikawa K, Toriyama S, Yamashita T, Tani Y, Yamada T, et al. Landiolol has a less potent negative inotropic effect than esmolol in isolated rabbit hearts. J Anesth. 2008;22:361–6.PubMedCrossRefGoogle Scholar
  11. 11.
    Sasao J, Tarver SD, Kindscher JD, Taneyama C, Benson KT, Goto H. In rabbits, landiolol, a new ultra-short-acting beta-blocker, exerts a more potent negative chronotropic effect and less effect on blood pressure than esmolol. Can J Anaesth. 2001;48:985–9.PubMedCrossRefGoogle Scholar
  12. 12.
    Weissman NJ, Levangie MW, Newell JB, Guerrero JL, Weyman AE, Picard MH. Effect of beta-adrenergic receptor blockade on the physiologic response to dobutamine stress echocardiography. Am Heart J. 1995;130:248–53.PubMedCrossRefGoogle Scholar
  13. 13.
    Everaert H, Vanhove C, Franken PR. Effect of beta-blockade on low-dose dobutamine-induced changes in left ventricular function in healthy volunteers: assessment by gated SPET myocardial perfusion scintigraphy. Eur J Nucl Med. 2000;27:419–24.PubMedCrossRefGoogle Scholar

Copyright information

© The Japanese Association for Thoracic Surgery 2012

Authors and Affiliations

  • Akimasa Morisaki
    • 1
    Email author
  • Mitsuharu Hosono
    • 1
  • Yasuyuki Sasaki
    • 1
  • Hidekazu Hirai
    • 1
  • Masanori Sakaguchi
    • 1
  • Atsushi Nakahira
    • 1
  • Hiroyuki Seo
    • 1
  • Shigefumi Suehiro
    • 1
  1. 1.Department of Cardiovascular SurgeryOsaka City University Graduate School of MedicineOsakaJapan

Personalised recommendations